Abstract
Objective
Polycyclic aromatic hydrocarbons in cigarette smoke induce cytochrome P450(CYP)1A2, which is involved in the hepatic metabolism of melatonin (MT). This suggests that habitual smokers may have low serum MT levels during smoking compared with a non-smoking period. We decided to investigate whether this suggestion is correct.
Methods
Eight habitual smokers were tested on two occasions. They had smoked prior to the first occasion but had not smoked for 7 days prior to the second. Each test was divided into two parts. The first part spanned the night between 2000 hours and 0800 hours. Venous blood samples were collected every second hour during this period for analysis of endogenous serum MT. The second part was performed the subsequent day. At 0930 hours, 25 mg MT was ingested orally, and blood samples for exogenous serum MT analysis were collected every hour between 1000 hours and 1600 hours. Endogenous and exogenous areas under the serum MT–time curve (MT-AUCs) were calculated.
Results
Endogenous serum MT-AUCs were similar during the two periods. Oral administration of MT induced supraphysiological levels of serum MT. Moreover, exogenous serum MT-AUCs were significantly smaller before than after smoking abstinence (7.34±1.85 versus 21.07±7.28 nmol/l×h; P<0.02; means±SEM).
Conclusion
This investigation shows that exogenous, but not endogenous (at night), serum MT levels are influenced by cigarette smoking. When the MT levels are low, the influence of CYP1A2 levels appears to be less pronounced than when they are high, and the enzyme capacity hugely utilized. These findings implicate that interactions between exogenous MT, and substrates metabolized by CYP1A2, may differ in individuals before and after smoking abstinence.
Similar content being viewed by others
References
Alvan G, Piafsky K, Lind M, von Bahr C (1977) Effect of pentobarbital on the disposition of alprenolol. Clin Pharmacol Ther 22:316–321
von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Röjdmark S (2000) Fluvoxamine but not citalopram increases serum melatonin in healthy subjects—an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur J Clin Pharmacol 56:123–127
Benowitz NL (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188–204
Benowitz NL, Jacob P 3rd (2000) Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin Pharmacol Ther 67:653–659
Carrillo JA, Christensen M, Ramos SI, Alm C, Dahl ML, Benitez J, Bertilsson L (2000) Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther Drug Monit 22:409–417
Caubet MS, Laplante A, Caille J, Brazier JL (2002) [13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake. Isotopes Environ Health Stud 38:71–77
Faber MS, Fuhr U (2004) Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76:178–184
Facciola G, Hidestrand M, von Bahr C, Tybring G (2001) Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur J Clin Pharmacol 56:881–888
Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH (1995) Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther 33:311–314
Grygiel JJ, Birkett DJ (1981) Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther 30:491–496
Härtter S, Ursing C, Morita S, Tybring G, von Bahr C, Christensen M, Röjdmark S, Bertilsson L (2001) Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study. Clin Pharmacol Ther 70:10–16
Kall MA, Clausen J (1995) Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man. Hum Exp Toxicol 14:801–807
Molander L, Lunell E, Andersson SB, Kuylenstierna F (1996) Dose released and absolute bioavailability of nicotine from a nicotine vapor inhaler. Clin Pharmacol Ther 59:394–400
Muranaka H, Higashi E, Itani S, Shimizu Y (1988) Evaluation of nicotine, cotinine, thiocyanate, carboxyhemoglobin, and expired carbon monoxide as biochemical tobacco smoke uptake parameters. Int Arch Occup Environ Health 60:37–41
Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155–1162
Rowland M (1972) Influence of route of administration on drug availability. J Pharm Sci 61:70–74
Schein JR (1995) Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 29:1139–1148
Schrenk D, Brockmeier D, Morike K, Bock KW, Eichelbaum M (1998) A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol 53:361–367
Tarquini B, Perfetto F, Poli R, Tarquini R (1994) Daytime circulating melatonin levels in smokers. Tumori 80:229–232
Ursing C, Wikner J, Brismar K, Röjdmark S (2003) Caffeine raises the serum melatonin level in healthy subjects—an indication of melatonin metabolism by cytochrome P450 (CYP) 1A2. J Endocrinol Invest 26:403–406
Walle T, Walle UK, Cowart TD, Conradi EC, Gaffrey TE (1987) Selective induction of propranolol metabolism by smoking: additional effects of renal clearance of metabolites. J Pharmacol Exp Ther 241:928–933
Wei C, Caccavale RJ, Kehoe JJ, Thomas PE, Iba MM (2001) CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett 171:113–120
Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 36:425–438
Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL (1995) Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 57:552–558
Acknowledgements
C. Häll, A.C. Larsson, E. Norén-Krog and I.L. Wivall are gratefully acknowledged for skillful experimental and technical assistance. The study was supported by grant no. 4224 from the Swedish Medical Research Council, and by Swedish Match.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ursing, C., Bahr, C.v., Brismar, K. et al. Influence of cigarette smoking on melatonin levels in man. Eur J Clin Pharmacol 61, 197–201 (2005). https://doi.org/10.1007/s00228-005-0908-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0908-7